Key result
Gut microbiota dysbiosis identifies CAD with an AUC of ~0.95.
Why the study?
Coronary artery disease is a leading global health issue, with growing evidence implicating gut microbiome dysbiosis in its pathogenesis.
Are there specific gut microbial signatures and dysbiosis patterns associated with coronary artery disease compared to healthy controls?
Observational (n=512)
Are there specific gut microbial signatures and dysbiosis patterns associated with coronary artery disease compared to healthy controls?
p-value: p=0.0000519
Gut microbiota dysbiosis is significantly associated with coronary artery disease, suggesting microbial signatures could serve as novel biomarkers for CAD risk assessment and diagnosis.
May support gut microbial signatures as CAD biomarkers; hypothesis-generating and requires prospective validation.
Background Coronary artery disease (CAD) remains a leading global health issue, with growing evidence implicating gut microbiome dysbiosis in its pathogenesis. This study characterized gut microbial alterations in previously reported data of 217 CAD patients compared to 57 healthy controls through advanced computational approaches and bioinformatics analysis. We employed an additional dataset to validate our results as well. Notably, our integrated approach, combining taxonomic profiling, core microbiome and co-occurrence network analyses, stochastic modelling, and machine learning, revealed significant CAD-associated microbial features. Results Our findings demonstrated that CAD is associated with specific changes in gut bacterial structure, diversity, composition, and stochastic signature, suggesting a dysbiosis in patients with CAD. The co-occurrence network for healthy controls further illustrated the robust and interconnected nature of the microbial community. Whereas, the CAD group showed a less interconnected and more fragmented microbial community. These changes in microbial population included the depletion of beneficial bacterial taxa and the enrichment of potentially harmful microorganisms. However, assessing the individual abundance of core microbiota at the genus level showed that only a small subset of gut core microbiota was correlated with CAD, although beneficial, may not fully compensate for the loss of other stabilizing taxa in the network. This suggests the importance of complex microbial interactions influencing overall health outcomes. We then identified the potential of gut microbial signatures as novel biomarkers for CAD risk assessment and diagnosis. Among those genera, Holdemanella, Acinetobacter, Fusicatenibacter, Sutterella, Agathobacter, Brevundimonas, Pseudomonas, Subdoligranulum, TM7x, and Delftia contributed the most. Conclusions Our study highlights a significant association between gut microbiota dysbiosis and CAD, characterized by distinct alterations in bacterial diversity and composition. Further research is needed to explore microbial dynamics across diverse populations and to clarify the role of microbiota in CAD onset and progression.
No takes yet. Share an insight, caveat, or question.
Alaeddini et al. (2025) conducted an observational in Coronary Artery Disease (CAD) (n=512). Gut microbiome composition analysis vs. Healthy controls was evaluated on Gut microbial diversity (Shannon index) and classification accuracy (p=0.0000519). Gut microbiota dysbiosis in patients with coronary artery disease is characterized by distinct alterations in bacterial diversity and composition, with a Random Forest model identifying health status with an AUC of 0.951.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: